These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 227202)

  • 1. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy.
    Moult PJ; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):153-62. PubMed ID: 6802531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
    Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
    J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):683-94. PubMed ID: 335758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine and oestrogen modulation of gonadotrophin release in normo- and hyperprolactinaemic patients with amenorrhoea.
    Djursing J; Hagen C; Christensen F; Nickelsen C
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):125-32. PubMed ID: 6796299
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.
    Glass MR; Shaw RW; Butt WR; Edwards RL; London DR
    Br Med J; 1975 Aug; 3(5978):274-5. PubMed ID: 1170923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of oestrogen-positive feedback effect on LH release in women with prolactinoma by transsphenoidal surgery.
    Koike J; Aono T; Tsutsumi H; Miyake A; Kurachi K
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):492-8. PubMed ID: 6289583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
    Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
    Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
    Thorner MO; Besser GM
    Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The control of gonadotrophin release in women with hyperprolactinaemic amenorrhoea: effect of oestrogen and progesterone on the LH and FSH response to LHRH.
    Glass MR; Shaw RW; Williams JW; Butt WR; Logan-Edwards R; London DR
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):521-30. PubMed ID: 791539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M; Rydner T; Carlström K
    Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.